National Research Corporation (NRC) Financials
NRC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | ? | ? |
| Sept. 30, 2023 | 120.1 million | 62.3 million |
| June 30, 2023 | 133.6 million | 55.9 million |
| March 31, 2023 | 134.3 million | 59.6 million |
NRC Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | ? | ? |
| Sept. 30, 2023 | 5.3 million | 68000 |
| June 30, 2023 | 4.5 million | 305000 |
| March 31, 2023 | 4.6 million | 304000 |
NRC Net Income
| Date | Net Income |
|---|---|
| Dec. 31, 2023 | 8.9 million |
| Sept. 30, 2023 | 7.9 million |
| June 30, 2023 | 7.3 million |
| March 31, 2023 | 7.0 million |
NRC Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | - | - | - |
| Sept. 30, 2023 | 3.8 million | - | - |
| June 30, 2023 | 22.5 million | 15.4 million | - |
| March 31, 2023 | 23.7 million | 16.5 million | - |
NRC Shares Outstanding
NRC Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | - | - | - |
| Sept. 30, 2023 | 4.5 million | - | 11.8 million | - |
| June 30, 2023 | 4.3 million | - | 3.0 million | - |
| March 31, 2023 | 3.2 million | - | 3.0 million | - |
NRC Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | - |
| Sept. 30, 2023 | 37.9 million | 14.6 million |
| June 30, 2023 | 36.2 million | 13.3 million |
| March 31, 2023 | 36.5 million | 14.3 million |
NRC
Price: $19.14
Dividend Yield: 2.84%
Forward Dividend Yield: 3.24%
Payout Ratio: 40.34%
Dividend Per Share: 0.56 USD
Earnings Per Share: 0.50 USD
P/E Ratio: 26.24
Exchange: NMS
Sector: Healthcare
Industry: Health Information Services
Country: United States
Volume: 12200
Market Capitalization: 445.1 million
Average Dividend Frequency: 4
Years Paying Dividends: 23
DGR3: -11.11%